Yanqun Xiang Selected Research

Drug Therapy (Chemotherapy)

1/2022	Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up.
11/2018	Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanqun Xiang Research Topics

Disease

15	Nasopharyngeal Carcinoma 01/2024 - 01/2006
11	Neoplasms (Cancer) 02/2024 - 01/2006
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2006
2	Carcinoma (Carcinomatosis) 09/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 03/2016
2	Carcinogenesis 01/2015 - 01/2006
1	Disease Progression 01/2015
1	Necrosis 01/2012

Drug/Important Bio-Agent (IBA)

4	Long Noncoding RNAIBA 01/2023 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 09/2019 - 05/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 09/2019 - 01/2018
1	ParaquatIBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	nitazoxanide (NTZ)FDA Link 06/2023
1	nimotuzumabIBA 06/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	AntibodiesIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	PlatinumIBA 11/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2016
1	Chemokine ReceptorsIBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	CytokinesIBA 03/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	thymidine kinase 1IBA 07/2013
1	Tumor Biomarkers (Tumor Markers)IBA 07/2013
1	EnzymesIBA 07/2013
1	Nucleic AcidsIBA 07/2013
1	ChemokinesIBA 01/2013
1	SurvivinIBA 01/2006

Therapy/Procedure

4	Radiotherapy 01/2023 - 01/2012
3	Immunotherapy 01/2024 - 03/2016
3	Chemoradiotherapy 06/2023 - 11/2018
2	Therapeutics 01/2024 - 10/2023
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2018
1	Induction Chemotherapy 01/2021